Alterations in Gut Microbiota by Statin Therapy and Possible Intermediate Effects on Hyperglycemia and Hyperlipidemia

Dysbiosis of the gut microbiota is a contributing factor for obesity-related metabolic diseases such as hyperglycemia and hyperlipidemia. Pharmacotherapy for metabolic diseases involves the modulation of gut microbiota, which is suggested to be a potential therapeutic target. In this study, the modu...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Front Microbiol
Главные авторы: Kim, Jiyeon, Lee, Heetae, An, Jinho, Song, Youngcheon, Lee, Chong-Kil, Kim, Kyungjae, Kong, Hyunseok
Формат: Artigo
Язык:Inglês
Опубликовано: Frontiers Media S.A. 2019
Предметы:
Microbiology
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6736992/
https://ncbi.nlm.nih.gov/pubmed/31551944
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmicb.2019.01947
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы